Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer [Phase 2]
Phase 2 trial update for NeoTAILOR, a biomarker-directed approach to guide neoadjuvant therapy in patients with stage II/III ER-positive, HE…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute's Cancer Moonshot Biobank update outlines the trial's status and scope, indicating the study is active but not rec…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery
The study on biospecimen collection to identify genetic changes in patients with various cancers undergoing surgery is currently suspended; …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial [Phase 2]
Phase 2 trial update evaluating the optimal Tamoxifen dose for breast cancer risk reduction in premenopausal women (RENAISSANCE). The study …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating the safety and potential efficacy of combining ZEN003694 with abemaciclib in adults and 12-17-year-old ped…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer [Phase 1]
This clinical trial update reports testing the addition of berzosertib to radiation therapy in patients with chemotherapy-resistant triple-n…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer [Phase 2]
A Phase 2 clinical trial comparing acolbifene versus low-dose tamoxifen for prevention of breast cancer in high-risk premenopausal women; cu…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors [Phase 1]
Open-label Phase 1 clinical trial evaluating BBO-10203 in adults with advanced, metastatic solid tumors; currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial [Phase 3]
Phase 3 RxFINE-Low trial is evaluating whether hormone therapy with ribociclib is as effective as chemotherapy followed by hormone therapy w…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer [Phase 2]
A Phase 2 trial evaluating serial circulating tumor DNA monitoring during adjuvant capecitabine in early triple-negative breast cancer is cu…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy [Phase 3]
Phase 3 clinical trial update for camizestrant in estrogen receptor–positive, HER2-negative early breast cancer after at least 2 years of ad…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating Inavolisib in combination with Fulvestrant for breast cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors [NA]
Clinical trial evaluating pencil beam scanning proton therapy for previously irradiated tumors, currently in recruiting status.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: System-integrated Point-of-Care Ultrasound in Breast Cancer Screening [NA]
Ongoing clinical trial evaluating system-integrated point-of-care ultrasound for breast cancer screening; recruitment is currently open.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: The Vanguard Study: Testing a New Way to Screen for Cancer [NA]
The Vanguard Study is a National Cancer Institute–sponsored cancer screening trial that is currently recruiting to evaluate a new screening …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer [Phase 2]
A Phase 2 study evaluating evorpacept in combination with trastuzumab and chemotherapy for metastatic HER2-positive breast cancer is current…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer
This clinical trial registry entry describes a study evaluating treatments for chemotherapy-induced peripheral neuropathy in cancer patients…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer [Phase 1]
This update describes a Phase 1 clinical trial of radiopharmaceuticals 68Ga-R11228 and 177Lu-R11228 in locoregionally recurrent or metastati…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer [Phase 1, Phase 2]
This entry reports a planned Phase 1/Phase 2 clinical trial evaluating abemaciclib in combination with bicalutamide for androgen receptor-po…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) [Phase 2]
This Phase 2 MATCH Screening Trial update describes ongoing evaluation of targeted therapies matched to genetic alterations in patients with…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations [Phase 2]
This clinical trial update describes a Phase 2 study evaluating talazoparib in patients with advanced cancers and DNA repair variations, and…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer [NA]
Clinical trial update describing an educational video intervention to improve patient understanding of tumor genomic testing in metastatic c…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction [Phase 1]
Phase 1 trial evaluating veliparib, paclitaxel, and carboplatin in patients with various metastatic or unresectable solid tumors and liver o…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Assessment of the Interi Manifold in Implant-Based Breast Reconstruction [NA]
This ClinicalTrials.gov entry indicates the Interi Manifold study for implant-based breast reconstruction is currently recruiting at Stanfor…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Baduanjin Exercise on Upper Limb Dysfunction Among Breast Cancer Survivors [NA]
Clinical trial evaluating Baduanjin exercise to improve upper limb dysfunction in breast cancer survivors. The study status is not yet recru…